Scott & Selber Inc’s Guardant Health GH Stock Holding History

Scott & Selber Inc’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,032	Closed	-$1.28M	–	80
2019 Q3	$1.28M	Buy	+20,032	New	+$1.76M	0.65%	59

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Scott & Selber Inc's GH Position: Q4 2019 in Review

Scott & Selber Inc sold out of Guardant Health (GH) in Q4 2019, closing a stake of 20,032 shares — an estimated $1.28M sold.

Scott & Selber Inc first reported a position in GH in Q3 2019 and held it in 1 quarter. The position peaked at $1.28M in Q3 2019. 268 funds tracked by Wall St. Rank hold GH as of Q4 2019.

Scott & Selber Inc reported no remaining Guardant Health position as of Q4 2019 after selling out during the quarter.
Scott & Selber Inc sold 20,032 Guardant Health shares in Q4 2019, an estimated $1.28M.
Scott & Selber Inc first reported a position in Guardant Health in Q3 2019 and held it in 1 quarter.
Scott & Selber Inc's Guardant Health position peaked at $1.28M in Q3 2019.
268 funds tracked by Wall St. Rank held Guardant Health as of Q4 2019.

Based on Scott & Selber Inc's 13F filing for Q4 2019, filed 7 Feb 2020.